47395
45076
S&P/TSX
16074.30
+0.72
(0.00%)
S&P-CDNX
792.78
+1.29
(0.16%)
S&P-500
2597.08
-1.95
(-0.08%)
NASDAQ
6867.36
+4.88
(0.07%)
Dow
23526.18
-64.65
(-0.27%)
Dollar
0.7863
-0.00025
(-0.031%)
Oil
58.38
-0.15
(-0.26%)
Gold
1292.35
+0.15
(+0.01%)
Silver
17.123
+0.011
(+0.06%)


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

48304
Recent Trending
45006
Castanet Proud Member of RTNDA Canada
47680
Press Room
48644